<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04824521</url>
  </required_header>
  <id_info>
    <org_study_id>2-21</org_study_id>
    <nct_id>NCT04824521</nct_id>
  </id_info>
  <brief_title>A Pilot Feasibility Study of Mindfulness-Oriented Recovery Enhancement With Pregnant Women With Opioid Use Disorder</brief_title>
  <official_title>The Mindful Pregnancy Study: A Pilot Feasibility Study of Mindfulness-Oriented Recovery Enhancement With Pregnant Women With Opioid Use Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Montana</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Montana</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Thirty pregnant women with substance use disorder will be recruited to participate in eight&#xD;
      sessions of MORE.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will be asked to complete a battery of self-report measures and a&#xD;
      semi-structured qualitative interview at three times points-before the intervention begins,&#xD;
      after session four, and again after session eight. Participants will also be asked to&#xD;
      complete self-report measures before and after each session. The primary aims of this study&#xD;
      are as follows.&#xD;
&#xD;
      Aim 1: To adapt the in-person MORE intervention for telehealth delivery. Aim 2: To assess the&#xD;
      overall feasibility and acceptability of this telehealth intervention. Hypothesis: MORE&#xD;
      delivered via telehealth will be both feasible and acceptable to participants.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 1, 2021</start_date>
  <completion_date type="Anticipated">May 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Client Satisfaction</measure>
    <time_frame>8 weeks</time_frame>
    <description>Participants will complete the Client Satisfaction Questionnaire.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Symptoms of substance use disorder</measure>
    <time_frame>8 weeks</time_frame>
    <description>Symptoms of substance use disorder will be assessed with the Mini-International Neuropsychiatric Interview 6.0.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Opioid-use Disorder</condition>
  <arm_group>
    <arm_group_label>Mindfulness-Oriented Recovery Enhancement via tele-health</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will be assigned to 8 weeks of Mindfulness-Oriented Recovery Enhancement delivered via tele-health.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindfulness-Oriented Recovery Enhancement</intervention_name>
    <description>MORE is a mindfulness-based intervention.</description>
    <arm_group_label>Mindfulness-Oriented Recovery Enhancement via tele-health</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Must be pregnant.&#xD;
&#xD;
          -  Must be able to communicate in English.&#xD;
&#xD;
          -  Must have met criteria for opioid use disorder in the past year.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  None.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>March 8, 2021</study_first_submitted>
  <study_first_submitted_qc>March 26, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2021</study_first_posted>
  <last_update_submitted>March 26, 2021</last_update_submitted>
  <last_update_submitted_qc>March 26, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Montana</investigator_affiliation>
    <investigator_full_name>Sarah Reese</investigator_full_name>
    <investigator_title>Assistant Professor of Social work</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Opioid-Related Disorders</mesh_term>
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

